Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.31, $0.11 better than the analyst estimate of $0.20. Revenue for the quarter came in at $301.6 million versus the consensus estimate of $300.17 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.